CLASS II ONGOING Device recall · Reported 27 Apr 2022 · FDA Enforcement Report

Gallant VR Implantable Cardioverter Defibrillator recalled

St. Jude Medical, Cardiac Rhythm Management Division is recalling Gallant VR Implantable Cardioverter Defibrillator, distributed nationwide in the US. The recall was initiated on 10 Mar 2022 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesREF# CDVRA500Q SN: 111009251, Exp Date : 31-Jul-2022, Material # 100173801; SN # 810000544, Exp Date: 31-Oct-2022, Material # 600115400 UDI# 05415067031990
Quantity recalled2

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-0989-2022
FDA event ID
89825
Classification
Class II
Status
Ongoing
Recall initiated
10 Mar 2022
FDA classified
21 Apr 2022
Reported
27 Apr 2022
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Device Malfunction

Timeline

10 Mar 2022Recall initiated by company
21 Apr 2022Classified by FDA+42 days
27 Apr 2022Published in enforcement report+6 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Bluetooth malfunction impacting Gallant devices post-implant. The failure causes the device to enter an inductive-only telemetry mode with a loss of Bluetooth communication. The Bluetooth malfunction results in the inability to remotely monitor these devices and resulted in reduced battery longevity.

Device recalls are issued when a component, software or design fault could cause the device to fail or give wrong readings. Many are corrections applied in the field rather than physical returns.

Product as listed by the FDA

Gallant VR Implantable Cardioverter Defibrillator REF # CDVRA500Q

Where it was distributed

Worldwide distribution - US Nationwide distribution in the states of FL, KY and the country of France, Czech Republic.

Nationwide FloridaKentucky

Questions about this recall

Why was it recalled?

Bluetooth malfunction impacting Gallant devices post-implant. The failure causes the device to enter an inductive-only telemetry mode with a loss of Bluetooth communication. The Bluetooth malfunction results in the inability to remotely monitor these devices and resulted in reduced battery longevity.

Which lots are affected?

REF# CDVRA500Q SN: 111009251, Exp Date : 31-Jul-2022, Material # 100173801; SN # 810000544, Exp Date: 31-Oct-2022, Material # 600115400 UDI# 05415067031990

Where was it sold?

Worldwide distribution - US Nationwide distribution in the states of FL, KY and the country of France, Czech Republic.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

Other products in this recall event

2 other products · FDA event 89825

This product is part of a recall event; the main page for the event is Gallant HF Implantable Cardioverter Defibrillator recalled.

More recalls from St. Jude Medical, Cardiac Rhythm Management Division

All 10

Other Pacemakers & Defibrillators recalls

All 494